Home

Results 61 - 70 of 451,583 for medical products. Search took 11.019 seconds.  
Sort by date/Sort by relevance
The WHO Prequalification Programme has greatly facilitated the access to quality medical products in developing countries (see Chapter IV, section B.7). (...) While estimates vary of the actual cost of medical research and product development, innovation is undoubtedly costly and time consuming. (...) Trade policy and the economics of global production systems, are also key factors in strategic plans to build domestic production capacity in medical products.
Language:English
Score: 829524.4 - https://www.wto.org/english/tr..._e/summary_trilat_web_13_e.htm
Data Source: un
The WHO Prequalification Programme has greatly facilitated the access to quality medical products in developing countries (see Chapter IV, section B.7). (...) While estimates vary of the actual cost of medical research and product development, innovation is undoubtedly costly and time consuming. (...) Trade policy and the economics of global production systems, are also key factors in strategic plans to build domestic production capacity in medical products.
Language:English
Score: 829524.4 - https://www.wto.org/english/tr..._e/summary_trilat_web_13_e.htm
Data Source: un
Output 2.1 : Production of mercury-free medical thermometers and sphygmomanometers achieved and sound management of obsolete mercury and stocks of mercury devices implemented in four (4) producers of mercury-containing medical thermometers and two (2) producers of mercury-containing sphygmomanometers. (...) The outcomes, and corresponding outputs and activities of this component, are the following: Outcome 3.1 : Production enterprises and medical facilities implemented appropriate strategies, tools and guidance to assure long-term sound management of mercury-containing medical devices and mercury contaminated areas. (...) The component will facilitate the complete phase out of production of mercury-containing medical thermometers and sphygmomanometers by 31 December 2025, and the successful promotion of wider application of mercury-free alternatives at local and national medical facilities.
Language:English
Score: 829471.5 - https://www.undp.org/sites/g/f...ry-Medical-Devices---ESMF.docx
Data Source: un
Only three equivalent products can be registered for each medication. 3. (...) The production and commercialization of medications, without authorization, or with suspended authorization is punishable with a 50.000$00 – 250.000$00 fine. 2. (...) Article 56 (Offer of abortive products, toxics and other medications without prescription) 1.
Language:English
Score: 829358.2 - https://www.wto.org/english/th...e/cpv_e/WTACCCPV15A1_LEG_1.pdf
Data Source: un
Regulation should promote access to medical technologies and should not unnecessarily delay the market entry of products. (...) Nevertheless, a number of LMICs aspire to build and strengthen their domestic medical products industry. Trends show that local production is growing and diversifying in some of these countries. 10 However, the evidence that local production results in increased access to medical products is inconclusive (WHO, 2011g). (...) Regulation of medical technologies plays a key role in determining access to quality-assured medical products.
Language:English
Score: 829294.5 - https://www.wto.org/english/tr...web_e/ch4b_trilat_web_13_e.htm
Data Source: un
“Access to high-quality medical products is a matter of life and death for everyone. (...) The presence of poor quality medical products on the market is the result of limited regulatory capacity to enforce best practices needed to develop, produce and distribute them. (...) At the same time as protecting consumers, SEARN will have a substantial impact on how the medical product market’s supply side functions. “As a major producer of medical products India is very much looking forward to SEARN’s full implementation of planned activities.
Language:English
Score: 828340.4 - https://www.who.int/southeasta...-high-quality-medical-products
Data Source: un
Select language Select language English South-East Asia India Home Health topics Our work News Emergencies About us Home / Day 1update Union Health Minister inaugurates ‘2019 World Conference on Access to Medical Products’ 19 November 2019, New Delhi:  The three-day 2019 World Conference on ‘Access to Medical Products: Achieving the SDGs 2030’ was inaugurated by Dr Harsh Vardhan, Union Minister of Health & Family Welfare and Science & Technology and Earth Sciences, Government of India in New Delhi today. (...) The conference will spur innovative thinking around issues surrounding provisioning of affordable, quality medical products as part of public health care delivery systems,” Dr Harsh Vardhan further added. (...) The Honourable Ministers also reiterated their commitment for access to medical products as envisioned in the 2018 Delhi Declaration.
Language:English
Score: 828322.5 - https://www.who.int/india/day-1-update
Data Source: un
As medical products are essential in the prevention, diagnosis and treatment of disease, the consequences of substandard and falsified medical products can be life threatening. This is a concern, as users of medical products are not usually in a position to judge their quality. (...) Responsiveness is time-bound and temporary, as it is necessary in urgent situations such as a public health emergency, serious shortages of a medical product with no alternative, an unmet medical need or rare disorder and medical products for compassionate use or donation.
Language:English
Score: 827885.6 - https://www.wto.org/english/tr...chsymp_290621/gaspar_pres2.pdf
Data Source: un
It is linked to the WHO Medical Product Alert N°1/2019 issued on 30 January 2019 regarding falsified Verorab rabies vaccines circulating in the Philippines. (...) All medical products must be obtained from authentic and reliable sources. (...) National health authorities are asked to immediately notify WHO if these falsified medical products are discovered in their country.
Language:English
Score: 827087.2 - https://www.who.int/news/item/...ert-n-8-2019-(english-version)
Data Source: un
In his address, Mr Naidu stated that the, “Andhra Pradesh MedTech Zone (AMTZ) envisioned to put India on the global map of high-end medical equipment production and make health care products affordable and accessible, not only for India, but for the world at large.” Dr Jitendar Sharma, MD and CEO of AMTZ said, ““The Andhra Pradesh MedTech Zone is a state-of-the-art infrastructure facility for quality and safe medical devices. There is a clear focus on bringing in innovation and providing easy and affordable access to health care products”. (...) Dr Soumya Swaminathan, Deputy Director General, WHO, in her video address, said that “Reliable access to effective, safe, quality-assured and affordable medical products is key to making progress towards universal health coverage (UHC) and the SDGs.”
Language:English
Score: 826055.8 - https://www.who.int/india/news...lobal-forum-on-medical-devices
Data Source: un